The Wrong Agency Can Burn Six Figures Before You Know What Happened

Selecting the right mass tort marketing agency is one of the highest-leverage financial decisions a plaintiff firm makes, directly affecting cost per signed case, intake efficiency, and overall portfolio risk. The market has grown crowded with vendors ranging from sophisticated, data-driven operators to firms that recycle leads across multiple clients and disappear when accountability is demanded. Understanding what separates those two categories before you commit a retainer protects both your acquisition budget and your docket.

What a Mass Tort Marketing Agency Actually Does for a Plaintiff Firm

At the operational level, a mass tort marketing agency runs the entire front end of your case acquisition pipeline. That means identifying the tort, building ad creative across whatever channels make sense (Meta, Google PPC, programmatic display, TV, radio, or some combination), deploying spend at scale, managing intake through a call center or internal screening process, qualifying claimants against your criteria, and delivering signed retainers. Some agencies stop at the lead. Others take you all the way to a fully executed retainer agreement with a pre-screened claimant. The difference matters enormously to your cost structure and your firm's capacity.

The better agencies bring tort-specific intelligence to the table, not just media buying. They know which torts have active MDL activity, what settlement timelines look like, which claimant pools are saturated and which have genuine runway. That upstream knowledge directly affects your return on case acquisition spend. A firm that gets into Ozempic or AFFF at the right moment with a disciplined campaign will see dramatically different economics than one that enters late, overpays for leads, and ends up with thin inventory in a crowded MDL.

Exclusive vs. Shared Leads: The Most Important Conversation You Are Not Having

Most agencies will tell you their leads are exclusive. Many are not telling the full truth. Shared leads, meaning a claimant who has been contacted by two, three, or five firms, convert at a fraction of the rate of a genuinely exclusive lead, and they drive up your cost per signed case in ways that do not always show up clearly in the agency's reporting. Before you engage any vendor, get specific answers in writing. Ask how the lead is defined as exclusive, whether that exclusivity is by tort category, by geography, or by individual claimant record. Ask what happens contractually if a duplicate is identified. Ask to audit a sample of delivered leads against your CRM to check for crossover.

The exclusivity question is also where some agencies hide margin. They buy co-registration leads or broad intent traffic cheaply, mark it up, call it exclusive, and charge you a premium. Genuine exclusivity costs more to produce because it requires purpose-built campaigns targeting specific claimants for a specific firm. That cost is real and worth paying. A signed case from an exclusive, properly screened claimant is worth multiples of a shared lead that never converts.

The Numbers: What Mass Tort Case Acquisition Actually Costs

There is no single answer, but I can give you the ranges firms should be benchmarking against. Across the $250 million in ad spend we have managed at MTAA for more than 600 plaintiff law firms across 100-plus torts, here is what realistic looks like by channel and tort category.

  • Meta (Facebook/Instagram): Cost per lead typically ranges from $80 to $250 depending on tort specificity and audience saturation. Cost per signed case after intake and qualification generally runs $800 to $2,500 for mid-tier torts with healthy claimant pools.
  • Google PPC: Higher intent, higher cost. Expect $150 to $400 per lead on competitive torts like Roundup or talc. Cost per signed case can push $3,000 to $5,000 when you factor full intake costs.
  • TV and radio: Better for brand-saturated torts where claimant awareness is already high. These channels move volume but require serious daily spend ($10,000 plus per market) to see results, and the intake infrastructure has to be ready before the phone rings.
  • High-value torts (AFFF, Depo-Provera, Hair Relaxer): Because claimant pools are more defined and case values are higher, firms often accept cost per signed case figures of $4,000 to $8,000 or more. The math still works if settlement values are substantial and the MDL is progressing.

Any agency quoting you flat rates without tort-specific context is giving you marketing material, not a real projection. Insist on benchmarks for the specific tort you are trying to build inventory in, and ask what those numbers looked like six months ago versus today. Claimant pool saturation moves fast.

How to Execute a Mass Tort Campaign Well: What Separates Winners from Money-Losers

The firms that build durable, profitable case inventory from paid campaigns share a few consistent habits. First, they treat intake as part of the campaign, not a downstream afterthought. A great media campaign that flows into a slow, unqualified intake process wastes the spend. Response speed matters: studies across the plaintiff firm space consistently show that lead conversion drops dramatically when first contact takes longer than five minutes. If your intake team is not set up to handle real-time inbound volume, fix that before you scale spend.

Second, they work from a tight qualification script. A mass tort campaign script should cover the specific exposure or product use, the timeline of use relative to the tort's qualifying criteria, any documented diagnosis or injury that affects case value, and basic jurisdictional facts. The script is not just a quality control tool. It is also your first line of defense on compliance. Claimants who are disqualified early cost you less than claimants who are signed and later fall out of the inventory review.

Third, they measure cost per signed case, not cost per lead. Lead volume is a vanity metric if conversion rates are broken. The only number that matters for case acquisition economics is what you actually paid, fully loaded, to get a signed retainer from a claimant who meets your criteria.

Pitfalls and Compliance: Where Firms Get Into Trouble

Mass tort advertising sits at the intersection of FTC rules, state bar advertising regulations, and TCPA and CIPA compliance, and the exposure on all three fronts is real. A few areas where firms consistently get caught off guard:

  • State bar solicitation rules: Many states impose specific restrictions on direct solicitation, required disclosures in advertising, and how quickly a firm can contact a claimant after an identifiable event. These rules vary significantly. Florida, Texas, and California all have distinct requirements. Your agency should be building state-specific compliance reviews into the creative approval process, not leaving that to you at the back end.
  • TCPA and CIPA exposure: Text and call-based outreach to potential claimants carries serious class action exposure if consent documentation is not airtight. The 2024 FCC updates to TCPA one-to-one consent rules tightened this further. Any agency running outbound calls or texts on your behalf needs to show you exactly how consent is captured and stored.
  • Misleading ad creative: The FTC has increased scrutiny of legal advertising that implies guaranteed outcomes or uses misleading settlement figures. Beyond federal exposure, bar complaints from competitors or regulators are a real risk if your creative is not reviewed for compliance before it runs.
  • Contractual risk with the agency itself: Read retainer agreements carefully. Watch for auto-renewal clauses, vague lead quality guarantees, and language that limits your recourse on duplicate or unqualified leads. A firm that delivers 500 leads against a contract with no quality definition has technically met its obligation even if zero convert.

How MTAA Approaches This Differently

At Mass Tort Ad Agency, we run campaigns on a transparent cost-plus model: you see every dollar of ad spend, and our fee is 15% of that spend. No hidden margin buried in lead costs, no opaque CPL pricing that obscures what you are actually paying for media. That structure aligns our incentives with yours. We scale what is working and pull back what is not, and you can verify the numbers at any time.

We have managed more than $250 million in Facebook ad spend alone for over 600 plaintiff law firms across more than 100 torts, including active campaigns in Roundup, AFFF, Ozempic, Depo-Provera, and Hair Relaxer. That volume gives us performance benchmarks that most agencies simply do not have. We know what a healthy cost per signed case looks like in a given tort at a given stage of MDL development, and we know when a market is getting saturated before our clients feel it in their conversion rates.

We also recognize that intake and operations are evolving fast. Firms using AI-assisted intake tools, automated lead scoring, and intelligent case management systems are building real competitive advantages in how efficiently they convert spend into signed inventory. For firms exploring that layer, the operational frameworks in "A Lawyer's Guide to AI" connect directly to how we think about building a smarter case acquisition pipeline from ad click to retainer.

Choosing the Right Mass Tort Marketing Agency: Final Checklist

Before you sign with any mass tort marketing agency, run through this list. Ask for verified performance data on torts similar to your target campaign. Get written exclusivity definitions in the contract. Confirm TCPA consent capture methodology and request a documentation sample. Review bar compliance workflows for states where you plan to advertise. Understand exactly how leads are qualified before they reach your intake team. And push hard on cost per signed case benchmarks, not just cost per lead, for the specific tort you are entering. The difference between a mass tort marketing agency that grows your firm and one that drains your operating budget almost always comes down to how clearly you asked these questions before the money moved.

Ready to Build Your Caseload?

Get a free campaign analysis from Mass Tort Ad Agency.

$250M+ in mass tort Facebook ad spend. 600+ law firms served. Transparent cost-plus pricing with no hidden fees.

Schedule a Free Consultation →

Frequently Asked Questions: How to Choose a Mass Tort Marketing Agency

What should plaintiff firms look for when vetting a mass tort marketing agency before signing a retainer?

Firms should demand transparency on lead exclusivity, clear reporting on cost per lead and cost per signed case, and verifiable references from other plaintiff firms in comparable torts. Red flags include agencies that cannot explain their qualification criteria, refuse to disclose where leads are simultaneously sold, or cannot produce auditable intake data from prior campaigns.

What does it typically cost to acquire a signed retainer in a mass tort campaign, and what benchmarks should firms use to evaluate agency performance?

Cost per signed case varies widely by tort, channel mix, and claimant pool saturation, but plaintiff firms should expect to benchmark against internal targets for case value and calculate whether acquisition cost leaves a viable margin after litigation expenses. An agency that cannot give you historical cost-per-signed-case figures from comparable torts is either inexperienced or unwilling to be accountable, and either condition is disqualifying.

How do firms assess whether a tort has enough claimant volume to justify a scaled marketing campaign?

Before committing spend, firms should pressure-test the agency's claimant pool estimates against independent exposure data, prior litigation filings, and any published epidemiological or product-sales records that define the universe of potentially injured people. A credible agency can model addressable volume by geography and channel and tell you honestly whether the pool supports the case count your firm needs to make the economics work.

What marketing channels and creative strategies are most effective for mass tort case acquisition, and how should agencies price those services?

Effective channel selection depends on the tort profile, but Meta and Google PPC typically drive the highest qualified lead volume for most mass torts, with TV and radio adding reach for older demographic targets. Firms should prefer agencies operating on a cost-plus model with full spend transparency rather than opaque flat-fee or undisclosed-margin structures, because cost-plus aligns the agency's incentives with efficient spend rather than inflated media markups.

How do firms protect themselves contractually when working with a mass tort marketing agency?

Contracts should explicitly define lead exclusivity, specify the qualification criteria a claimant must meet before billing is triggered, establish audit rights over ad spend and intake data, and include performance benchmarks with clawback or termination provisions if those benchmarks are missed. Firms should also require written confirmation that the agency is not simultaneously running the same tort for direct competitors in overlapping markets.